1 |
Effective suppression of C5a-induced proinflammatory response using anti-human C5a repebody. Biochem Biophys Res Commun. 2016 Sep 2;477(4):1072-1077.
|
2 |
Targeted delivery of a human Bcl-2-specific protein binder effectively induces apoptosis of cancer cells. Biochem Biophys Res Commun. 2020 May 28;526(2):447-452.
|
3 |
Protein binder for affinity purification of human immunoglobulin antibodies. Anal Chem. 2014 Jun 17;86(12):6019-25.
|
4 |
Design of a binding scaffold based on variable lymphocyte receptors of jawless vertebrates by module engineering. Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3299-304.
|
5 |
Anti-Human VEGF Repebody Effectively Suppresses Choroidal Neovascularization and Vascular Leakage. PLoS One. 2016 Mar 25;11(3):e0152522.
|
6 |
Btk SH2-kinase interface is critical for allosteric kinase activation and its targeting inhibits B-cell neoplasms. Nat Commun. 2020 May 8;11(1):2319.
|
7 |
Enzymatic prenylation and oxime ligation for the synthesis of stable and homogeneous protein-drug conjugates for targeted therapy. Angew Chem Int Ed Engl. 2015 Oct 5;54(41):12020-4. doi: 10.1002/anie.201505964. Epub 2015 Aug 28.
|
8 |
A high-affinity protein binder that blocks the IL-6/STAT3 signaling pathway effectively suppresses non-small cell lung cancer. Mol Ther. 2014 Jul;22(7):1254-1265.
|